Guy Marson, co-founder of the data science consultancy Profusion, says "hotels are the perfect test bed" for technology, particularly the internet of things and smart devices.
Mike Weston, CEO of the data science consultancy Profusion, said: "American companies are going to have to restructure how they manage, store and use data in Europe and this takes a lot of time and money.
Mike Weston, the chief executive of data science consultancy Profusion, said that: "The EU's vote opens the door to an end to net neutrality in Europe that could severely damage tech companies and consumers.
He said in an interview that a previous report commissioned by Pacific Northwest from the science consultancy Stantec Consulting Ltd. had gathered no data on fish, but still concluded the area around Lelu Island, known as Flora Bank, was not an important habitat.
Furthermore, Francesca Tamma, an economics advisor at a behavioral science policy consultancy based in London, concludes that "we base our estimates on our reference group and we have a limited understanding of what the income distribution actually is".
Bioeconomy professionals from industry, consultancy, science and policy circles and NGOs meet regularly, in different kinds of settings, often enabled by or as part of public private bioeconomy development programmes.
If solving problems, using your analytical skills, exploring unknown territory, and learning while you are working appeals to you more than the science itself, management consultancy might be a good choice for you.
In a recent report, National Review documented several problems, including that it has ties to a public-relations consultancy, Science First, that gets money from groups with an environmental agenda.
Smith (2009) states that "this advisory group would be made up of appropriate subject experts from across universities, crown research institutes and other science organisations including consultancies, [and] … could play both an operational role (during events) and a strategic role for planning science activities" (p. 76).
AC has received research funding from Baxter, Gilead Sciences, MSD and Pfizer; consultancy fees from Gilead Sciences, MSD, and ViiV Healthcare; lecture and travel sponsorships from Gilead Sciences, MSD, and ViiV Healthcare and has served on advisory boards for Gilead Sciences, MSD, and ViiV Healthcare.
With that, my career took a major turn towards consultancy in science and technology.
